Search research articles
Contact Us
Filters
Showing results (51-60 of 58) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 58 results.
Plos One
|
June 12, 2026
Evaluating respiratory syncytial virus immunization strategies for infants in Canada: A cost-utility analysis
Gebremedhin B Gebretekle, Marie Lan, Min Xi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 28, 2023
Single-dose Effectiveness of Mpox Vaccine in Quebec, Canada: Test-negative Design With and Without Adjustment for Self-reported Exposure Risk
Nicholas Brousseau, Sara Carazo, Yossi Febriani, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
December 14, 2021
SARS-CoV-2 seroprevalence in health care workers from 10 hospitals in Quebec, Canada: a cross-sectional study
Nicholas Brousseau, Laurianne Morin, Manale Ouakki, et al.
Human Vaccines & Immunotherapeutics
|
January 13, 2026
Parental acceptability of new RSV preventive therapies for infants: A cross-sectional survey in Canada
Tiffany Fitzpatrick, Jeanna Parsons Leigh, Rebecca Brundin-Mather, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC
|
November 10, 2018
Vaccination Against Influenza in Pregnancy: A Survey of Canadian Maternity Care Providers
Eve Dubé, Dominique Gagnon, Kyla Kaminsky, et al.
Human Vaccines & Immunotherapeutics
|
April 10, 2020
Vaccination during pregnancy: Canadian maternity care providers' opinions and practices
Eve Dubé, Dominique Gagnon, Kyla Kaminsky, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 19, 2022
Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada
Danuta M Skowronski, Yossi Febriani, Manale Ouakki, et al.
Cell Host & Microbe
|
December 26, 2021
Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses
Alexandra Tauzin, Shang Yu Gong, Guillaume Beaudoin-Bussières, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 58) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 58 results.
Plos One
|
June 12, 2026
Evaluating respiratory syncytial virus immunization strategies for infants in Canada: A cost-utility analysis
Gebremedhin B Gebretekle, Marie Lan, Min Xi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 28, 2023
Single-dose Effectiveness of Mpox Vaccine in Quebec, Canada: Test-negative Design With and Without Adjustment for Self-reported Exposure Risk
Nicholas Brousseau, Sara Carazo, Yossi Febriani, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
December 14, 2021
SARS-CoV-2 seroprevalence in health care workers from 10 hospitals in Quebec, Canada: a cross-sectional study
Nicholas Brousseau, Laurianne Morin, Manale Ouakki, et al.
Human Vaccines & Immunotherapeutics
|
January 13, 2026
Parental acceptability of new RSV preventive therapies for infants: A cross-sectional survey in Canada
Tiffany Fitzpatrick, Jeanna Parsons Leigh, Rebecca Brundin-Mather, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC
|
November 10, 2018
Vaccination Against Influenza in Pregnancy: A Survey of Canadian Maternity Care Providers
Eve Dubé, Dominique Gagnon, Kyla Kaminsky, et al.
Human Vaccines & Immunotherapeutics
|
April 10, 2020
Vaccination during pregnancy: Canadian maternity care providers' opinions and practices
Eve Dubé, Dominique Gagnon, Kyla Kaminsky, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 19, 2022
Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada
Danuta M Skowronski, Yossi Febriani, Manale Ouakki, et al.
Cell Host & Microbe
|
December 26, 2021
Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses
Alexandra Tauzin, Shang Yu Gong, Guillaume Beaudoin-Bussières, et al.
Page
of 6